JP Morgan Chase
FLNA

JP Morgan Chase’s Filana Therapeutics FLNA Stock Holding History

JP Morgan Chase’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-77,500
Closed -$183K – 7679
2024
Q4 		$183K Buy
+77,500
New +$1.36M ﹤0.01% 5513
2023
Q4 		– Sell
-200,000
Closed -$3.33M – 7833
2023
Q3 		$3.33M Buy
+200,000
New +$3.96M ﹤0.01% 3139
2021
Q1 		– Sell
-20,300
Closed -$138K – 6313
2020
Q4 		$138K Buy
20,300
+19,300
+1,930% +$172K ﹤0.01% 4918
2020
Q3 		$11K Buy
+1,000
New +$4.51K ﹤0.01% 5247

Other funds holding FLNA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

JP Morgan Chase's FLNA Position: Q2 2026 in Review

JP Morgan Chase increased its Filana Therapeutics (FLNA) stake by 130,923% in Q2 2026, buying an estimated $24.2K and bringing the position to 17,033 shares worth $20.8K. The position accounts for ﹤0.01% of the portfolio, ranked #6725.

JP Morgan Chase first reported a position in FLNA in Q2 2013 and has held it in 32 quarters since. The position peaked at $2.21M in Q2 2021. 84 funds tracked by Wall St. Rank hold FLNA as of Q2 2026.

  • JP Morgan Chase held 17,033 shares of Filana Therapeutics worth $20.8K as of Q2 2026.
  • JP Morgan Chase bought 17,020 Filana Therapeutics shares in Q2 2026, an estimated $24.2K.
  • Filana Therapeutics made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #6725 holding.
  • JP Morgan Chase first reported a position in Filana Therapeutics in Q2 2013 and has held it in 32 quarters since.
  • JP Morgan Chase's Filana Therapeutics position peaked at $2.21M in Q2 2021.
  • 84 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.